Pharmacokinetic studies in humans with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one.
Pharmacokinetic studies have been carried out with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1). HPLC analysis of serum of a normal volunteer and seven transfusional iron loaded patients who ingested a 3 gm dose of L1 revealed that L1 was most probably absorbed from the stomach and was transferred to the blood with a half-life of 0.7 to 32 minutes. L1 reached maximum concentration in the serum 12 to 120 minutes after administration with 85% to 90% elimination within the first 5 to 6 hours, with a half-life of 47 to 134 minutes. L1 and its glucuronide metabolite were identified in serum and urine but not in feces. In most cases hydrolysis of 24-hour urine samples with use of beta-glucuronidase resulted in almost complete recovery of the administered dose. Urinary iron excretion was proportional to the iron load but not to the serum or urine concentration of L1. The therapeutic efficiency of L1 can therefore be improved by repeated administration of 2 to 3 gm doses at least every 6 hours.
Department of Haematology, Royal Free Hospital School of Medicine, London, England.
G J
GJ
Kontoghiorghes
J G
JG
Goddard
A N
AN
Bartlett
L
L
Sheppard
D000328:Adult; D000368:Aged; D000077543:Deferiprone; D005260:Female; D005966:Glucuronidase; D006207:Half-Life; D006801:Humans; D007501:Iron / Q000652:urine; D007502:Iron Chelating Agents / Q000493:pharmacokinetics*; D008297:Male; D008875:Middle Aged; D011728:Pyridones / Q000493:pharmacokinetics* / Q000652:urine; D014168:Transferrin / Q000032:analysis
D007502:Iron Chelating Agents; D011728:Pyridones; D014168:Transferrin; D000077543:Deferiprone; D007501:Iron; D005966:Glucuronidase